EP Patent

EP1275391A1 — Pharmaceutical compositions containing irbesartan and a diuretic

Assigned to Sanofi SA · Expires 2003-01-15 · 23y expired

What this patent protects

Pharmaceutical compositions containing irbesartan in combination with a diuretic providing tablets with a high relative amount of active agent and excellent wetting and disintegration properties.

USPTO Abstract

Pharmaceutical compositions containing irbesartan in combination with a diuretic providing tablets with a high relative amount of active agent and excellent wetting and disintegration properties.

Drugs covered by this patent

naldemedine-tosylate (NALDEMEDINE TOSYLATE)

Patent Metadata

Patent number: EP1275391A1
Jurisdiction: EP
Classification: —
Expires: 2003-01-15
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.